PT  - JOURNAL ARTICLE
AU  - Rizzo, Toni
ED  - Bonaca, Marc P.
TI  - PEGASUS-TIMI 54 Subanalysis
DP  - 2015 Nov 21
TA  - MD Conference Express
PG  - 20--21
VI  - 15
IP  - 28
4099  - http://mdc.sagepub.com/content/15/28/20.short
4100  - http://mdc.sagepub.com/content/15/28/20.full
AB  - The PEGASUS-TIMI 54 trial demonstrated that continuing treatment with ticagrelor after 1 year following myocardial infarction protected patients from ischemic events and provided a more robust risk reduction compared to reinitiation in stable patients on aspirin monotherapy. Patients who were treated with only aspirin for > 1year after myocardial infarction did not derive any benefit from reinitiation of P2Y12 inhibitor therapy and had an increased risk of bleeding.